• Users Online: 95329
  • Home
  • Print this page
  • Email this page
This article has been cited by
1POLYPOIDAL CHOROIDAL VASCULOPATHY
Adrian H.C. Koh,Lee-Jen Chen,Shih-Jen Chen,Youxin Chen,Anantharam Giridhar,Tomohiro Iida,Hakyoung Kim,Timothy Yuk Yau Lai,Won Ki Lee,Xiaoxin Li,Tock Han Lim,Paisan Ruamviboonsuk,Tarun Sharma,Shibo Tang,Mitsuko Yuzawa
Retina.2013;33(4)686
[DOI]
2Genetic risk, ethnic variations and pharmacogenetic biomarkers in AMD and polypoidal choroidal vasculopathy
Jane Z Kuo,Tien Y Wong,Frank S Ong
Expert Review of Ophthalmology.2013;8(2)127
[DOI]
3Reduced-Fluence Photodynamic Therapy in Polypoidal Choroidal Vasculopathy Nonresponsive to Ranibizumab
Ik Soo Byon,Han Jo Kwon,Sung Il Kim,Min Kyu Shin,Sung Who Park,Ji Eun Lee
Ophthalmic Surgery, Lasers and Imaging Retina.2014;45(6)534
[DOI]
4Polypoidal Choroidal Vasculopathy in Asians
Chee Wong,Tien Wong,Chui Cheung
Journal of Clinical Medicine.2015;4(5)782
[DOI]
5Two-Year Results of Reduced-Fluence Photodynamic Therapy for Polypoidal Choroidal Vasculopathy
Ayana Yamashita,Fumio Shiraga,Chieko Shiragami,Yukari Shirakata,Atsushi Fujiwara
American Journal of Ophthalmology.2013;155(1)96
[DOI]
6Age-related macular degeneration and polypoidal choroidal vasculopathy in Asians
Chee Wai Wong,Yasuo Yanagi,Won-Ki Lee,Yuichiro Ogura,Ian Yeo,Tien Yin Wong,Chui Ming Gemmy Cheung
Progress in Retinal and Eye Research.2016;53(1)107
[DOI]
7Polypoidal choroidal vasculopathy treatment options: A meta-analysis
Tianwei Qian,Xinxin Li,Mengya Zhao,Xun Xu
European Journal of Clinical Investigation.2018;48(1)107
[DOI]
8Photodynamic therapy versus anti-vascular endothelial growth factor agents for polypoidal choroidal vasculopathy: A meta-analysis
Meng Yong,Minwen Zhou,Guohua Deng
BMC Ophthalmology.2015;15(1)107
[DOI]
9CFH Y402H polymorphism and response to intravitreal Ranibizumab in brazilian patients with neovascular age-related macular degeneration
Carlos Eduardo Veloso,Luciana Negrão Frota de Almeida,Márcio Bittar Nehemy
Revista do Colégio Brasileiro de Cirurgiões.2014;41(6)386
[DOI]
10Comparison of the effects of photodynamic therapy, intravitreal ranibizumab and combination for polypoidal choroidal vasculopathy under 1?+?PRN regimen
Kunbei Lai,Ying Li,Lijun Zhou,Xiaojin Zhong,Chuangxin Huang,Fabao Xu,Lin Lu,Jian Ge,Chenjin Jin
BMC Ophthalmology.2018;18(1)386
[DOI]
11Effect of intravitreal injection of bevacizumab in treated and untreated eyes of Black African patients with polypoidal choroidal vasculopathy
N.N. Kabedi,D.L. Kayembe,J.C. Mwanza
Journal Français d'Ophtalmologie.2021;44(10)1505
[DOI]
12VEGF Gene Polymorphism and Response to Intravitreal Ranibizumab in Neovascular Age-Related Macular Degeneration
Carlos Eduardo dos Reis Veloso,Luciana Negrão Frota de Almeida,Franco Maria Recchia,David Pelayes,Márcio Bittar Nehemy
Ophthalmic Research.2014;51(1)1
[DOI]
13Reply
Sérgio Leal,Rufino Silva,João Figueira,M Luz Cachulo,Isabal Pires
Retina.2011;31(1)200
[DOI]
14Leitlinien zur Behandlung der feuchten Makuladegeneration
Michael Stur
Spektrum der Augenheilkunde.2011;25(1)51
[DOI]

Subscribe this journal
Submit articles
Most popular articles
Joiu us as a reviewer
Email alerts
Recommend this journal